Shmulik Hess
Operationeel Directeur bij MEDIWOUND LTD.
Profiel
Dr. Shmulik Hess is a Chief Operating & Commercial Officer at MediWound Ltd.
Dr. Hess was previously employed as a Chief Executive Officer by Valin Technologies Ltd., a Global Operations by SciGen Ltd., a Chief Executive Officer by Active PX Ltd., a Chief Executive Officer by Enlivex Therapeutics Ltd., and a Chief Executive Officer by Tabby Therapeutics Ltd.
He received his doctorate degree from The Hebrew University of Jerusalem.
Actieve functies van Shmulik Hess
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDIWOUND LTD. | Operationeel Directeur | 01-12-2023 |
Eerdere bekende functies van Shmulik Hess
| Bedrijven | Functie | Einde |
|---|---|---|
| Valin Technologies Ltd. | Algemeen Directeur | 01-11-2018 |
Active P Ltd.
 Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Algemeen Directeur | 01-09-2011 |
| SCIGEN LIMITED | Operationeel Directeur | 01-03-2010 |
| ENLIVEX THERAPEUTICS LTD. | Algemeen Directeur | - |
Tabby Therapeutics Ltd.
 Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Algemeen Directeur | - |
Opleiding van Shmulik Hess
| The Hebrew University of Jerusalem | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| MEDIWOUND LTD. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
| Valin Technologies Ltd. | |
Tabby Therapeutics Ltd.
Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Health Technology |
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
